Article
Regimens for Cirrhotic Patients.
Clinics in liver disease - 1 Nov 2015
Kwo Paul Y
Abstract excerpt
Therapy for hepatitis C has entered the era of all-oral direct-acting antiviral agents. Sustained response rates are now greater than 90% for all genotypes, although patients with cirrhosis remain the most difficult to treat. There are limited data for patients with cirrhosis and with hepatitis C genotypes 4 and 6 with cirrhosis. Genotype 3 patients with cirrhosis need additional strategies to achieve the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
